Fortrea (NASDAQ:FTRE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings [Yahoo! Finance]
Laboratory Corporation of America Holdings (LH)
Last laboratory corporation of america holdings earnings: 4/29 06:53 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=84636&p=irol-irhome
Company Research
Source: Yahoo! Finance
The company's full-year revenue guidance of $2.6 billion at the midpoint came in 4.9% below analysts' estimates. Its non-GAAP profit of $0.09 per share was 43.8% below analysts' consensus estimates. Is now the time to buy Fortrea? Find out in our full research report Fortrea (FTRE) Q4 CY2025 Highlights: Revenue: $660.5 million vs analyst estimates of $666.8 million (5.2% year-on-year decline, 0.9% miss) Adjusted EPS: $0.09 vs analyst expectations of $0.16 (43.8% miss) Adjusted EBITDA: $54 million vs analyst estimates of $50.09 million (8.2% margin, 7.8% beat) EBITDA guidance for the upcoming financial year 2026 is $205 million at the midpoint, in line with analyst expectations Operating Margin: -2.1%, up from -8% in the same quarter last year Free Cash Flow Margin: 18.4%, up from 2.9% in the same quarter last year Market Capitalization: $955.4 million “We finished 2025 with solid results for the fourth quarter, as the Fortrea team's shared commitment to commercial,
Show less
Read more
Impact Snapshot
Event Time:
LH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LH alerts
High impacting Laboratory Corporation of America Holdings news events
Weekly update
A roundup of the hottest topics
LH
News
- Weitz Partners III Opportunity Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
- A longevity researcher started taking testosterone in his 50s. He says there are 4 things everyone should know before considering TRT. [Business Insider]Business Insider
- Labcorp expands PathAI pact to roll out digital pathology platform in US [Yahoo! Finance]Yahoo! Finance
- Labcorp (NYSE:LH) had its "neutral" rating reaffirmed by analysts at Piper Sandler.MarketBeat
- Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform NationwidePR Newswire
LH
Earnings
- 2/17/26 - Beat
LH
Sec Filings
- 2/27/26 - Form 144
- 2/26/26 - Form 4
- 2/24/26 - Form 10-K
- LH's page on the SEC website